Emergency bypass post percutaneous atrial ablation: A case report

Perfusion

Volumn 25, Issue 6, 2010, Pages 423-424

  Hargrove, M ^a   Marshall, C B ^a   Jahanjir, S ^a   Hinchion, J ^a  

^a University College Cork and INFANT Centre   (Ireland)

Author keywords

cardiopulmonary bypass; catheter ablation; tamponade

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ANAMNESIS; ARTICLE; BYPASS SURGERY; CARDIOPULMONARY BYPASS; CASE REPORT; ERYTHROCYTE TRANSFUSION; HEART CATHETERIZATION; HEART TAMPONADE; HEMOPERICARDIUM; HUMAN; MALE; PERICARDIUM; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; STERNOTOMY;

ADULT; ANTICOAGULANTS; BLOOD TRANSFUSION; CARDIAC TAMPONADE; CARDIOPULMONARY BYPASS; CATHETER ABLATION; HEART ATRIA; HUMANS; MALE;

EID: 78649683978     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659110381154     Document Type: Article

References (5)

1. Cappato R., Calkins H., Chen S-A., et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Col Cardiol 2009 ; 53: 1798-1803.
2. Global markets for atrial fibrillation treatment devices 2008. Millennium Research Group. Market Research Reports March 2008.
3. Fetsch T., Bauer P., Engberding R., et al. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 2004 ; 25: 1385-1394.
4. Kono T., Kitahara H., Sakaguchi M., Amano J. Cardiac rupture after catheter ablation procedure. Ann Thorac Surg 2005 ; 80: 326-328.
5. Belhassen B. A 1 per 1,000 mortality rate after catheter ablation of atrial fibrillation; an acceptable risk? JACC 2009: 53: 1804-1806.